HIV-I
Also known as: Human Immunodeficiency Virus 1 / Human Immunodeficiency Virus-Type 1 / Human Immunodeficiency Virus-1 (HIV-1) / Human Immunodeficiency Virus Type 1 (HIV-1) / Human Immunodeficiency Virus-1 / Immunodeficiency Virus Type 1, Human / Human Immunodeficiency Virus Type 1 / HIV-1 / Human Immunodeficiency Virus - Type 1 / Human T-cell leukemia virus III / Human T-cell leukaemia virus III / Human immunodeficiency virus type I (organism) / Human immunodeficiency virus [HIV] disease / HIV disease / HIV infection NOS / Human immunodeficiency virus syndrome / HIV Infections / HIV infection / Human immunodeficiency virus infection (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB11751 | Cabotegravir | An HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. |
DB12301 | Doravirine | A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. |
DB00109 | Enfuvirtide | An HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals. |
DB08864 | Rilpivirine | A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to specifically treat human immunodeficiency virus type 1 (HIV-1). |